US Patent 7214684 Methods for the treatment of allergic rhinitis
Patent 7214684 was granted and assigned to Sepracor on May, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
A. K. Gunnar Aberg0
Emil R. Smith0
John R. McCullough0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+266 characters)
Article
Patent abstract
Methods are disclosed utilizing DCL, a metabolic derivative of loratadine, for the treatment of allergic rhinitis, and other disorders, while avoiding the concomitant liability of adverse side-effects associated with other non-sedating antihistamines.
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07214684 Methods for the treatment of allergic rhinitis US Patent 7214684 Methods for the treatment of allergic rhinitis
Infobox
Patent Number
072146840
Patent Number
72146840
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
072146840
Date of Patent
May 8, 2007
0Patent Application Number
109895140
Date Filed
November 17, 2004
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 21 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07214684 Methods for the treatment of allergic rhinitis
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07214684
Date of patent
May 8, 2007
Patent application number
10989514
Date Filed
November 17, 2004
Patent primary examiner
Find more entities like US Patent 7214684 Methods for the treatment of allergic rhinitis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
